Polycystic ovary syndrome: clinical manifestations, diagnostic evaluation and therapeutic management – A review of current evidence (2020–2025)
Humanities & Social Sciences Reviews · 24.07.2026 · 14 (2) · 29-37
DOI: 10.18510/hssr.2026.1424 ↗Kurz gefasst
Fachartikel in der Zeitschrift Humanities & Social Sciences Reviews, online erschienen am 24.07.2026. Verfasst von Maria Morawska und 11 weiteren Autor:innen. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-SA 4.0).
Abstract (Originalsprache)
Research objective: The aim of this study is to present current knowledge on the clinical manifestations, diagnostic evaluation, and therapeutic management of polycystic ovary syndrome (PCOS), based on evidence published between 2020 and 2025. Methodology: The study is based on a review of recent scientific literature concerning PCOS, with particular attention to its heterogeneous clinical presentation, current diagnostic criteria, associated metabolic and cardiovascular risks, and individualized treatment strategies. Main conclusions: PCOS is a common endocrine disorder (about 10–13%) affecting reproductive, metabolic, and mental health. Symptoms vary, including irregular ovulation, high androgens, obesity, insulin resistance, skin issues, and psychological effects, and it raises risks for type 2 diabetes and cardiovascular disease. Diagnosis uses modified Rotterdam criteria with AMH improving accuracy. Treatment emphasizes lifestyle changes plus tailored medications. Application of the study: The findings may support clinicians in the individualized diagnosis and management of PCOS, taking into account its metabolic and cardiovascular implications as well as patient preferences. Originality/Novelty of the study: The review integrates recent evidence from 2020–2025 on PCOS, highlighting the evolving diagnostic role of AMH and emerging research directions, including the gut microbiome, AMH as a potential mediator of disease pathogenesis, and the growing recognition of PCOS as a cardiovascular risk factor.
Zitieren
APA
Morawska, M., Siwiec, A., Jakubik, M., Kiżewska, M., Szymczyk, K., Dargacz, A., Szczepańska, D., Ożga, A., Kozikowska, J., Owczarzak, M., Gajos, A., & Wójcik, Z. (2026). Polycystic ovary syndrome: clinical manifestations, diagnostic evaluation and therapeutic management – A review of current evidence (2020–2025). Humanities & Social Sciences Reviews, 14(2), 29-37. https://doi.org/10.18510/hssr.2026.1424
Vancouver
Morawska M, Siwiec A, Jakubik M, Kiżewska M, Szymczyk K, Dargacz A, et al. Polycystic ovary syndrome: clinical manifestations, diagnostic evaluation and therapeutic management – A review of current evidence (2020–2025). Humanities & Social Sciences Reviews. 2026;14(2):29-37. doi:10.18510/hssr.2026.1424
BibTeX
@article{Morawska2026,
author = {Morawska, Maria and Siwiec, Agnieszka and Jakubik, Maciej and Kiżewska, Marta and Szymczyk, Klaudia and Dargacz, Anna and Szczepańska, Diana and Ożga, Alicja and Kozikowska, Julia and Owczarzak, Marta and Gajos, Aleksandra and Wójcik, Zuzanna},
title = {Polycystic ovary syndrome: clinical manifestations, diagnostic evaluation and therapeutic management – A review of current evidence (2020–2025)},
journal = {Humanities & Social Sciences Reviews},
year = {2026},
volume = {14},
number = {2},
pages = {29--37},
doi = {10.18510/hssr.2026.1424}
}
EUVIMED